New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

XLV

State Street Health Care Select Sector SPDR ETF

The XLV Exchange Traded Fund (ETF) is provided by State Street Investment Management. It is built to track an index: S&P Health Care Select Sector Index. The XLV ETF provides physical exposure, so by buying it you actually own parts of all the 59 underlying holdings. This share class generates a stream of income by distributing dividends.

$159.25
-$1.8 (-1.14%) yesterday
1:30 PM 07/20/26 Closed
1D price range
$159.18$161.49
52W price range
$128.99$164.50
YTD Perf.
+4.97%
YTD Flows
Annualized volatility
Fund AuM
€36.55B
Share class AuM
€36.55B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US81369Y2090
TER
0.08%
Inception date
12/16/1998
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 17, 2026
-5%0%5%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
97.58%
Consumer Non-Cyclicals
2.14%
Unavailable
0.28%
Latest XLV news

No content available for this fund

FAQ about XLV

XLV is a Passive ETF. This ETF provides exposure to Large Cap US Health Care Equities.
XLV tracks the S&P Health Care Select Sector Total Return Index - USD, through a full replication replication method.
XLV carries a total expense ratio (TER) of 0.08%, indicating the annual cost for holding the fund.
XLV was introduced to the market on December 16, 1998. It trades on United States
State Street Health Care Select Sector SPDR ETF, XLV, is provided by State Street Investment Management. Learn more about State Street Investment Management here.
XLV oversees €36.55B in assets as of July 17, 2026.
XLV follows a distributing dividend policy, meaning it pays out income to investors. As of July 17, 2026, its 12-month trailing yield was 1.57%.
As of May 31, 2026, XLV has significant geographic allocations in USA and Ireland.
As of May 31, 2026, XLV focuses largely on Healthcare and Consumer Non-Cyclicals.
As of May 31, 2026, XLV holds 59 positions in its portfolio, with 71.84% of assets concentrated in its top 15 holdings.
As of May 31, 2026, XLV top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of XLV is USD.
Data as of 05/31/26
Eli Lilly & Co.
16.19%
Johnson & Johnson
10.04%
AbbVie, Inc.
7.12%
UnitedHealth Group, Inc.
6.37%
Merck & Co., Inc.
5.45%
Thermo Fisher Scientific, Inc.
3.42%
Amgen, Inc.
3.35%
Gilead Sciences, Inc.
3.08%
Intuitive Surgical, Inc.
2.79%
Pfizer Inc.
2.75%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight